Mr. Yrjö Närhinen becomes an Investor and Strategic Advisor for Nightingale Health to accelerate its international growth
Nightingale Health Oy (“Nightingale”), a market leader in advanced blood-testing for preventative health solutions, announced today that Mr. Yrjö Närhinen becomes an investor and strategic advisor for Nightingale. This partnership is an important step for Nightingale as the company looks to make its unique blood testing technology available in several international markets.“We are delighted to have Mr. Närhinen as an investor, but more importantly, we are very honoured to have one of the most experienced healthcare professionals in Europe to support us in taking Nightingale’s technology to